Starke Robert M, Chalouhi Nohra, Jabbour Pascal M, Tjoumakaris Stavropoula I, Gonzalez L Fernando, Rosenwasser Robert H, Wada Kosuke, Shimada Kenji, Hasan David M, Greig Nigel H, Owens Gary K, Dumont Aaron S
Joseph and Marie Field Cerebrovascular Research Laboratory, Division of Neurovascular and Endovascular Surgery, Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
J Neuroinflammation. 2014 Apr 16;11:77. doi: 10.1186/1742-2094-11-77.
Alterations in TNF-α expression have been associated with cerebral aneurysms, but a direct role in formation, progression, and rupture has not been established.
Cerebral aneurysms were induced through hypertension and a single stereotactic injection of elastase into the basal cistern in mice. To test the role of TNF-α in aneurysm formation, aneurysms were induced in TNF-α knockout mice and mice pretreated with the synthesized TNF-α inhibitor 3,6'dithiothalidomide (DTH). To assess the role of TNF-α in aneurysm progression and rupture, DTH was started 6 days after aneurysm induction. TNF-α expression was assessed through real-time PCR and immunofluorescence staining.
TNF-α knockout mice and those pre-treated with DTH had significantly decreased incidence of aneurysm formation and rupture as compared to sham mice. As compared with sham mice, TNF-α protein and mRNA expression was not significantly different in TNF-α knockout mice or those pre-treated with DTH, but was elevated in unruptured and furthermore in ruptured aneurysms. Subarachnoid hemorrhage (SAH) occurred between 7 and 21 days following aneurysm induction. To ensure aneurysm formation preceded rupture, additional mice underwent induction and sacrifice after 7 days. Seventy-five percent had aneurysm formation without evidence of SAH. Initiation of DTH treatment 6 days after aneurysm induction did not alter the incidence of aneurysm formation, but resulted in aneurysmal stabilization and a significant decrease in rupture.
These data suggest a critical role of TNF-α in the formation and rupture of aneurysms in a model of cerebral aneurysm formation. Inhibitors of TNF-α could be beneficial in preventing aneurysmal progression and rupture.
肿瘤坏死因子-α(TNF-α)表达的改变与脑动脉瘤有关,但在其形成、进展和破裂中的直接作用尚未明确。
通过高血压及向小鼠基底池单次立体定向注射弹性蛋白酶诱导脑动脉瘤形成。为检测TNF-α在动脉瘤形成中的作用,在TNF-α基因敲除小鼠及用合成的TNF-α抑制剂3,6'-二硫代沙利度胺(DTH)预处理的小鼠中诱导动脉瘤形成。为评估TNF-α在动脉瘤进展和破裂中的作用,在动脉瘤诱导后6天开始给予DTH。通过实时聚合酶链反应(PCR)和免疫荧光染色评估TNF-α表达。
与假手术小鼠相比,TNF-α基因敲除小鼠及用DTH预处理的小鼠动脉瘤形成和破裂的发生率显著降低。与假手术小鼠相比,TNF-α基因敲除小鼠或用DTH预处理的小鼠中TNF-α蛋白和mRNA表达无显著差异,但在未破裂及破裂的动脉瘤中均升高。蛛网膜下腔出血(SAH)发生在动脉瘤诱导后7至21天。为确保动脉瘤形成先于破裂,另外的小鼠在诱导后7天处死。75%的小鼠有动脉瘤形成但无SAH证据。在动脉瘤诱导后6天开始DTH治疗未改变动脉瘤形成的发生率,但导致动脉瘤稳定且破裂显著减少。
这些数据表明TNF-α在脑动脉瘤形成模型中动脉瘤的形成和破裂中起关键作用。TNF-α抑制剂可能有助于预防动脉瘤进展和破裂。